Indices and ferritin level that predict organ involvement in adult-onset Still's disease

Mehmet Nur Kaya1, Özlem Kılıç1, Ezgi Çimen Güneş1

  • 1University of Health Sciences Turkey, Gülhane Training & Research Hospital, Rheumatology Department, Ankara, 38100, Turkey.

Biomarkers in Medicine
|September 24, 2024
PubMed

Insights

Inflammatory markers like lactate dehydrogenase to albumin ratio (LAR) and C-reactive protein to albumin ratio (CAR) can predict organ involvement in adult-onset Still's disease (AOSD). Ferritin levels and other indices also show predictive value for specific organ manifestations in AOSD patients.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder.
  • Organ involvement is a significant complication in AOSD, impacting patient prognosis.
  • Predictive markers for organ involvement in AOSD are crucial for early diagnosis and management.

Purpose of the Study:

  • To evaluate the predictive value of various inflammatory and nutritional indices for organ involvement in AOSD.
  • To assess the utility of C-reactive protein to albumin ratio (CAR), lactate dehydrogenase to albumin ratio (LAR), ferritin to erythrocyte sedimentation rate ratio (FER), systemic immune-inflammation index (SII), prognostic nutritional index (PNI), and ferritin level.

Main Methods:

  • Cross-sectional study design.
  • Inclusion of sixty-one adult patients diagnosed with AOSD.
  • Application of univariate and multivariate logistic regression analyses to determine predictive capabilities of markers.

Main Results:

  • Multivariate analysis identified LAR as a predictor of lymphadenopathy (OR 1.028, p=0.001).
  • CAR predicted hepatomegaly (OR 1.249, p=0.002), and ferritin level predicted splenomegaly (OR 1.004, p=0.007).
  • FER (OR 1.085, p=0.021) and PNI (OR 0.271, p<0.001) predicted serositis.

Conclusions:

  • Ferritin level, CAR, FER, PNI, and LAR are potential predictors of organ involvement at diagnosis in AOSD.
  • These markers can aid in identifying patients at risk for specific organ manifestations.
  • Further research may validate these findings for clinical application in AOSD management.